Oral Rehydration Solution Market Summary
Global Oral Rehydration Solution Market Size was valued at USD 5.87 Billion in 2024 & the market is projected to grow from USD 6.14 Billion in 2025 to USD 9.56 Billion by 2035, registering a CAGR of 4.53% during the forecast period 2025–2035. North America led the market with over 30.66% share, generating around USD 1.8 Billion in revenue.
The rising prevalence of dehydration caused by diarrhea, heat stress, infectious diseases, and inadequate fluid intake is a major growth driver for the Oral Rehydration Solution (ORS) Market. Increasing awareness of rapid rehydration therapy and preventive healthcare continues to strengthen global demand for accessible and effective ORS products.
According to the WHO, diarrheal diseases cause approximately 1.7 billion cases annually among children worldwide, reinforcing the critical role of oral rehydration therapy in preventing dehydration and supporting broader adoption of ORS products across healthcare settings.
Key Market Trends & Highlights
The Oral Rehydration Solution Market is experiencing robust growth driven by health awareness and innovation.
- North America accounted for over 30.66% of global Oral Rehydration Solution Market revenue in 2024, maintaining regional leadership.
- Europe generated USD 1.17 billion in revenue during 2024, representing approximately 19.93% of the global market.
- Diarrhea Treatment accounted for approximately 42% of market revenue in 2024, maintaining leadership across application categories globally.
- Powdered Formulation captured nearly 48% market share in 2024, supported by extended shelf life and distribution efficiency.
- Pharmacies generated approximately 51% of distribution channel revenue in 2024, benefiting from strong consumer trust and accessibility.
- Children represented nearly 46% of end-user revenue in 2024, reflecting high demand for pediatric dehydration management solutions.
Market Size & Forecast
| 2024 Market Size | 5.87 (USD Billion) |
| 2035 Market Size | 9.56 (USD Billion) |
| CAGR (2025 - 2035) | 4.53% |
Major Players
Companies such as Bristol-Myers Squibb (US), Baxter International (US), GlaxoSmithKline (GB), Reckitt Benckiser (GB), Procter & Gamble (US), Danone (FR), Nestle (CH), Abbott Laboratories (US), Haleon (GB) are some of the major participants in the market.